Roffman R A
Int J Addict. 1986 Aug;21(8):883-96. doi: 10.3109/10826088609027401.
Fifty-four marijuana-naive cancer patients undergoing chemotherapy and about to use THC (delta-9-tetrahydrocannabinol) as an antiemetic for the first time were randomly assigned to one of two conditions: stress inoculation or placebo/information training. It was hypothesized that subjects exposed to stress inoculation training would experience fewer adverse subjective effects of THC, experience less stressful nausea and vomiting, and be less likely to voluntarily withdraw from subsequent THC trials. None of the hypotheses was confirmed.
54名首次接受化疗且即将首次使用四氢大麻酚(delta-9-四氢大麻酚,THC)作为止吐药的未吸食过大麻的癌症患者被随机分配到两种情况之一:应激接种或安慰剂/信息训练。研究假设,接受应激接种训练的受试者THC的不良主观影响会更少,应激性恶心和呕吐会更少,并且不太可能自愿退出后续的THC试验。但这些假设均未得到证实。